Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Holoclar 79,000 - 316,000 cells/cm2 living tissue equivalent {equilateral_black_triangle}

Active Ingredient:
ex vivo expanded autologous human corneal epithelial cells containing stem cells
Company:  
Holostem Terapie Avanzate s.r.l See contact details
ATC code: 
S01XA19
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 23 Jul 2021

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Holostem Terapie Avanzate s.r.l
Company image
Address
Via Glauco Gottardi, 100, Modena (MO), 41125, Italy
WWW
www.holostem.com
Telephone
0039 0592 058 070
Fax
0039 059 205 8115
E-mail
[email protected]
Customer Care direct line
0039 340 59 036 08